Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. (Q54393922)

29 May 2018

title

Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. (English)

1 reference

29 May 2018

1 reference

5

Kypros H Nicolaides

1 reference

29 May 2018

Ramesh Kuppusamy

3

object named as

Ramesh Kuppusamy

1 reference

29 May 2018

Ranjit Akolekar

1

object named as

Ranjit Akolekar

1 reference

29 May 2018

author name string

Kirstin Finning

2

1 reference

29 May 2018

Geoff Daniels

4

1 reference

29 May 2018

publication date

8 January 2011

1 reference

29 May 2018

Fetal Diagnosis and Therapy

published in

1 reference

29 May 2018

volume

29

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

301-306

1 reference

29 May 2018

Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma

cites work

1 reference

Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service

21 January 2018

1 reference

Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.

21 January 2018

1 reference

Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008

21 January 2018

1 reference

Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects

21 January 2018

1 reference

Non-invasive antenatal RHD typing

21 January 2018

1 reference

Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study

21 January 2018

1 reference

Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha

21 January 2018

1 reference

Prenatal genotyping of RHD and SRY using maternal blood.

21 January 2018

1 reference

Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma.

21 January 2018

1 reference

Fetal rhd genotyping from maternal plasma in a population with a highly diverse ethnic background.

21 January 2018

1 reference

Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies

21 January 2018

1 reference

The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis

21 January 2018

1 reference

Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.

21 January 2018

1 reference

Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

21 January 2018

1 reference

Presence of fetal DNA in maternal plasma and serum

21 January 2018

1 reference

UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation

21 January 2018

1 reference

Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000322959

1 reference

29 May 2018

1 reference

29 May 2018